Contraception and fertility-associated advisement is needed for any individual with a uterus who is engaging in sexual activity with reproductive potential. As greater awareness spreads regarding the health care needs of transgender, nonbinary, and gender-nonconforming individuals, the research on evidence-based care for these populations lags behind. Many clinicians may not be well versed in the best practices to support the sexual and reproductive well-being of individuals who are taking gender-affirming hormone therapy. This article reviews the use of contraception for individuals who are on testosterone gender-affirming hormone therapy. Each contraceptive method is individually considered for the risks and benefits that are unique to this population.
No takes yet. Share an insight, caveat, or question.
Boudreau et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: